Industry Strength Score
11/100
Composite price performance score based on 3, 6, and 12-month returns, with more weight on recent trends.
THERMOGENESIS HOLDINGS INC (THMO) Stock Price & Overview
NASDAQ:THMO • US88362L2097
Current stock price
0.3102 USD
-0.11 (-25.84%)
At close:
0.3161 USD
+0.01 (+1.9%)
After Hours:
The current stock price of THMO is 0.3102 USD. Today THMO is down by -25.84%. In the past month the price decreased by -40.41%. In the past year, price decreased by -76.85%.
THMO Key Statistics
52-Week Range0.3101 - 1.82
Current THMO stock price positioned within its 52-week range.
1-Month Range0.3101 - 0.875
Current THMO stock price positioned within its 1-month range.
- Market Cap
- 2.466M
- P/E
- N/A
- Fwd P/E
- 1.52
- EPS (TTM)
- -4.28
- Dividend Yield
- N/A
THMO Stock Performance
Today
-25.84%
1 Week
-46.52%
1 Month
-40.41%
3 Months
-59.13%
Longer-term
6 Months -57.51%
1 Year -76.85%
2 Years -97.50%
3 Years -99.74%
5 Years N/A
10 Years N/A
THMO Stock Chart
THMO Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to THMO. When comparing the yearly performance of all stocks, THMO is a bad performer in the overall market: 97.96% of all stocks are doing better.
Chartmill TA Rating
Chartmill Setup Rating
THMO Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to THMO. THMO may be in some trouble as it scores bad on both profitability and health.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
THMO Earnings
On May 17, 2024 THMO reported an EPS of -0.46 and a revenue of 2.74M. The company missed EPS expectations (-4609.8% surprise) and missed revenue expectations (-29.39% surprise).
Next Earnings DateAug 8, 2024
Last Earnings DateMay 17, 2024
PeriodQ1 / 2024
EPS Reported-$0.46
Revenue Reported2.737M
EPS Surprise -4,609.80%
Revenue Surprise -29.39%
THMO Forecast & Estimates
7 analysts have analysed THMO and the average price target is 5.1 USD. This implies a price increase of 1544.1% is expected in the next year compared to the current price of 0.3102.
For the next year, analysts expect an EPS growth of 102.13% and a revenue growth 48.46% for THMO
Analysts
Analysts82.86
Price Target5.1 (1544.1%)
EPS Next Y102.13%
Revenue Next Year48.46%
THMO Financial Highlights
Over the last trailing twelve months THMO reported a non-GAAP Earnings per Share(EPS) of -4.28. The EPS increased by 76.7% compared to the year before.
Income Statements
Revenue(TTM)9.60M
Net Income(TTM)-14.75M
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -146.23% | ||
| ROE | -1512.82% | ||
| Debt/Equity | 4.31 |
Chartmill High Growth Momentum
EPS Q2Q%-15233.33%
Sales Q2Q%6.42%
EPS 1Y (TTM)76.7%
Revenue 1Y (TTM)-7.66%
THMO Ownership
Ownership
Inst Owners0.02%
Shares7.95M
Float3.51M
Ins OwnersN/A
Short Float %0.01%
Short Ratio0
THMO Industry Overview
THMO operates in the Health Care Equipment sub-industry within the Health Care sector. This group contains 127 stocks and is scored by ChartMill on both price strength and growth momentum.
Industry Growth Score
61/100
Composite growth score based on earnings growth, revenue growth, and profitability across the sub-industry.
Relative Performance
Each rank shows how many other sub-industries were outperformed over that timeframe.
1 Month Rank
17%
Outperformed 17% of sub-industries
3 Month Rank
12%
Outperformed 12% of sub-industries
6 Month Rank
10%
Outperformed 10% of sub-industries
Industry Fundamentals & Breadth
- Members
- 127
- New Highs
- 3.2%
- New Lows
- 13.4%
- Average ROE
- 17.1%
- Average Profit Margin
- 20.3%
- Average Operating Margin
- 22.5%
- Average P/E
- 28.4
- Average Fwd P/E
- 26.8
- Average Debt/Equity
- 0.5
THMO Competitors/Peers
The largest stocks on the US markets in the "Health Care Equipment" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ISRG | INTUITIVE SURGICAL INC | 39.23 | 162.529B | ||
| ABT | ABBOTT LABORATORIES | 14.45 | 157.763B | ||
| SYK | STRYKER CORP | 18.62 | 120.688B | ||
| BSX | BOSTON SCIENTIFIC CORP | 14.59 | 85.619B | ||
| EW | EDWARDS LIFESCIENCES CORP | 24.75 | 48.141B | ||
| IDXX | IDEXX LABORATORIES INC | 37.87 | 44.539B | ||
| BDX | BECTON DICKINSON AND CO | 10.92 | 42.438B | ||
| RMD | RESMED INC | 17.41 | 31.148B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 10.71 | 27.761B | ||
| DXCM | DEXCOM INC | 19.59 | 22.918B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 9.05 | 15.956B | ||
| PEN | PENUMBRA INC | 64.05 | 12.837B | ||
| GMED | GLOBUS MEDICAL INC - A | 19.78 | 12.197B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About THMO
Company Profile
ThermoGenesis Holdings, Inc. engages in the research, development, commercialization, and marketing of automated cell processing technologies for the cell and gene therapy field. The company is headquartered in Rancho Cordova, California and currently employs 40 full-time employees. The company provides the AutoXpress and BioArchive platforms for automated clinical bio-banking, PXP platform for point-of-care cell-based therapies and the CAR-TXpress platform for large scale cell manufacturing services. Its products include Clinical Bio-Banking Applications, Point-of-Care Applications and Large-Scale Cell Processing and Biomanufacturing. Its Clinical Bio-Banking Applications include AXP Automated Cell Separation System and BioArchive Automated Cryopreservation System. Its Point-of-Care Applications include PXP Point-of-Care System, PXP-LAVARE System and PXP-1000 System. Its Large-Scale Cell Processing and Biomanufacturing includes X-Series Products for general laboratory use and CAR-TXpress Platform for Clinical Manufacturing. AXP Automated Cell Separation System is an automated, fully closed cell separation system.
Company Info
IPO: 1987-06-05
THERMOGENESIS HOLDINGS INC
2711 Citrus Rd
Rancho Cordova CALIFORNIA 95742 US
CEO: Chris Xu
Employees: 40
Phone: 19168585100
THERMOGENESIS HOLDINGS INC / THMO FAQ
What does THERMOGENESIS HOLDINGS INC do?
ThermoGenesis Holdings, Inc. engages in the research, development, commercialization, and marketing of automated cell processing technologies for the cell and gene therapy field. The company is headquartered in Rancho Cordova, California and currently employs 40 full-time employees. The company provides the AutoXpress and BioArchive platforms for automated clinical bio-banking, PXP platform for point-of-care cell-based therapies and the CAR-TXpress platform for large scale cell manufacturing services. Its products include Clinical Bio-Banking Applications, Point-of-Care Applications and Large-Scale Cell Processing and Biomanufacturing. Its Clinical Bio-Banking Applications include AXP Automated Cell Separation System and BioArchive Automated Cryopreservation System. Its Point-of-Care Applications include PXP Point-of-Care System, PXP-LAVARE System and PXP-1000 System. Its Large-Scale Cell Processing and Biomanufacturing includes X-Series Products for general laboratory use and CAR-TXpress Platform for Clinical Manufacturing. AXP Automated Cell Separation System is an automated, fully closed cell separation system.
Can you provide the latest stock price for THERMOGENESIS HOLDINGS INC?
The current stock price of THMO is 0.3102 USD. The price decreased by -25.84% in the last trading session.
Does THERMOGENESIS HOLDINGS INC pay dividends?
THMO does not pay a dividend.
What is the ChartMill technical and fundamental rating of THMO stock?
THMO has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
Which stock exchange lists THMO stock?
THMO stock is listed on the Nasdaq exchange.
What is the employee count for THMO stock?
THERMOGENESIS HOLDINGS INC (THMO) currently has 40 employees.
Who owns THERMOGENESIS HOLDINGS INC?
You can find the ownership structure of THERMOGENESIS HOLDINGS INC (THMO) on the Ownership tab.